Article: Anti-Influenza Drug Discovery and Development: Targeting the Virus and Its Host by All Possible Means.
Advances in experimental medicine and biology
2021 Volume 1322, Page(s) 195–218
Abstract: Infections by influenza virus constitute a major and recurrent threat for human health. Together with vaccines, antiviral drugs play a key role in the prevention and treatment of influenza virus infection and disease. Today, the number of antiviral ... ...
Abstract | Infections by influenza virus constitute a major and recurrent threat for human health. Together with vaccines, antiviral drugs play a key role in the prevention and treatment of influenza virus infection and disease. Today, the number of antiviral molecules approved for the treatment of influenza is relatively limited, and their use is threatened by the emergence of viral strains with resistance mutations. There is therefore a real need to expand the prophylactic and therapeutic arsenal. This chapter summarizes the state of the art in drug discovery and development for the treatment of influenza virus infections, with a focus on both virus-targeting and host cell-targeting strategies. Novel antiviral strategies targeting other viral proteins or targeting the host cell, some of which are based on drug repurposing, may be used in combination to strengthen our therapeutic arsenal against this major pathogen. |
---|---|
MeSH term(s) | Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use ; Drug Discovery ; Humans ; Influenza, Human/drug therapy ; Orthomyxoviridae ; Orthomyxoviridae Infections ; Virus Replication |
Chemical Substances | Antiviral Agents |
Language | English |
Publishing date | 2021-07-13 |
Publishing country | United States |
Document type | Journal Article |
ISSN | 2214-8019 ; 0065-2598 |
ISSN (online) | 2214-8019 |
ISSN | 0065-2598 |
DOI | 10.1007/978-981-16-0267-2_8 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.